Wiebke Stark
Goettingen, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: June 23, 2026
Pretreatment Neurofilament Light Chain Serum Levels, Early Disease Severity, and Treatment Response in Pediatric Multiple Sclerosis.
Journal: Neurology
Published: June 08, 2023
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 20, 2019
Therapy of highly active pediatric multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 22, 2017
Continuing role for classical cytogenetics: Case report of a boy with ring syndrome caused by complete ring chromosome 4 and review of literature.
Journal: American journal of medical genetics. Part A
Published: July 02, 2016
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severity.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 30, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026